Results of a Phase II Trial of Carboplatin, Pemetrexed, and Bevacizumab for the Treatment of Never or Former/Light Smoking Patients With Stage IV Non-Small Cell Lung Cancer

Clinical Lung Cancer
Jared M WeissThomas E Stinchombe

Abstract

Bevacizumab- and pemetrexed-based therapies have demonstrated activity in patients with non-small-cell lung cancer (NSCLC) and nonsquamous histologic features. Patients with history of never or light smoking might derive greater benefit from these therapies. The included patients had stage IIIB (malignant pleural effusion) or IV NSCLC with nonsquamous histologic features, adequate organ function, no contraindications to bevacizumab, and no previous cytotoxic therapy. The patients had also never smoked or had smoked ≤ 10 pack years and had quit ≥ 1 year before enrollment. The patients had received 4 cycles of carboplatin (area under the curve, 6), pemetrexed 500 mg/m(2), and bevacizumab 15 mg/kg. Patients without disease progression initiated maintenance therapy with pemetrexed and bevacizumab. A single-arm phase II trial with the primary endpoint of progression-free survival (PFS) was performed. The secondary endpoints were the objective response rate (ORR), overall survival (OS), and toxicity. From March 2010 to November 2013, 38 eligible patients were enrolled and treated in the trial. The most common histologic type was adenocarcinoma (97%). Most of the patients were women (66%) and never smokers (63%). The median PFS was 12...Continue Reading

References

Jun 5, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Y K TanA Seow
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vincent A MillerRobert T Heelan
May 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chee-Keong TohEng-Huat Tan
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Feb 28, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jenifer L MarksWilliam Pao
May 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giorgio Vittorio ScagliottiDavid Gandara
May 13, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jyoti D PatelPhilip D Bonomi
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Sep 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Charles M RudinJonathan M Samet
Jan 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suzanne E DahlbergDavid H Johnson
Dec 2, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Giorgio ScagliottiChandra P Belani
Feb 22, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·D Ross CamidgeRobert C Doebele
Jun 7, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jeong-Ok LeeYung-Jue Bang
Jul 1, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jong-Mu SunMyung-Ju Ahn
May 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pasi A JänneVincent A Miller
Aug 14, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A T ShawG V Scagliotti
Aug 18, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C ChargariE Deutsch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.